Clinical Trial Update: Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating early administration of PCSK9 inhibitors after thrombectomy in patients with acute ischemic stroke due to atherosclerosis; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Evolocumab (evolocumab)
• alirocumab (alirocumab)

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Acute Stroke | Phase 4 | Status: RECRUITING